Pharma Organizations in Bangladesh

• 
  Bangladesh Pharmaceutical Society (BPS)
• 
  Bangladesh Association of Pharmaceutical Industries (BAPI)
• 
  Pharmacy Graduates' Association (PGA), Bangladesh
• 
  Bangladesh Pharmacy Students Association (BPSA)

Pharma Organizations in Bangladesh

• 
  Bangladesh Pharmaceutical Society (BPS)
• 
  Bangladesh Association of Pharmaceutical Industries (BAPI)
• 
  Pharmacy Graduates' Association (PGA), Bangladesh
• 
  Bangladesh Pharmacy Students Association (BPSA)

Pharma Organizations in Bangladesh

• 
  Bangladesh Pharmaceutical Society (BPS)
• 
  Bangladesh Association of Pharmaceutical Industries (BAPI)
• 
  Pharmacy Graduates' Association (PGA), Bangladesh
• 
  Bangladesh Pharmacy Students Association (BPSA)

Bangladesh Becomes Global Hub of Medicines

Mar. 25, 2009 (The Korea Times) — The pharmaceutical sector in Bangladesh, one of the fastest growing sectors of the economy, is poised to transform the country into a global hub of quality medicines.
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more

Bangladesh Becomes Global Hub of Medicines

Mar. 25, 2009 (The Korea Times) — The pharmaceutical sector in Bangladesh, one of the fastest growing sectors of the economy, is poised to transform the country into a global hub of quality medicines.
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more

Bangladesh Becomes Global Hub of Medicines

Mar. 25, 2009 (The Korea Times) — The pharmaceutical sector in Bangladesh, one of the fastest growing sectors of the economy, is poised to transform the country into a global hub of quality medicines.
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more

Beximco Pharma Is First Pharmaceutical Company From Bangladesh To EnterLatin America

Beximco Pharmaceuticals Ltd., the leading edge pharmaceutical manufacturer and the largest pharmaceutical exporter of Bangladesh has commenced exports to Chile, after receiving marketing authorization for a number of products from "Instituto de Salud Publica de Chile" (Drug Regulatory authority in Chile). With this, BPL has become the first Bangladeshi pharmaceutical company to obtain product registration in any Latin American country, a company statement said today. Read more